• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

A Consumerized Diagnostic: Looking Back And Ahead On A Decade Of Cologuard

cafead

Administrator
Staff member
  • cafead   Aug 15, 2024 at 11:42: AM
via On its 10th anniversary, Cologuard offers a clear model for other companies looking to bring diagnostics to market: focus on enabling a seamless, consumerized experience.

article source